[Juvenile rheumatoid arthritis].
Maeno
N
N
Department of Pediatrics, Faculty of Medicine, Kagoshima University.
Takei
S
S
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000145:classification / Q000628:therapy; D003937:Diagnosis, Differential; D016228:Endothelial Growth Factors; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015850:Interleukin-6; D008222:Lymphokines; D026741:Physical Therapy Modalities; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D016228:Endothelial Growth Factors; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D011239:Prednisolone